Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Alpha 2-adrenoceptors: more subtypes but fewer functional differences

A C MacKinnon1, M Spedding, C M Brown

  • 1Syntex Research Centre, Heriot-Watt University, Riccarton, Edinburgh, UK.

Trends in Pharmacological Sciences
|April 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Compartment-guided assembly of large-scale molecular models with Bentopy.

Protein science : a publication of the Protein Society·2026
Same author

Public reporting guidelines for outbreak data: Enabling accountability for effective outbreak response by developing standards for transparency and uniformity.

Public health·2025
Same author

Photosymbiosis reduces the environmental stress response under a heat challenge in a facultatively symbiotic coral.

Scientific reports·2024
Same author

Néel ordering in the distorted honeycomb pyrosilicate: C-Er<sub>2</sub>Si<sub>2</sub>O<sub>7</sub>.

Journal of physics. Condensed matter : an Institute of Physics journal·2020
Same author

The therapeutic potential of galectin-3 inhibition in fibrotic disease.

The international journal of biochemistry & cell biology·2020
Same author

Common acoustic phonon lifetimes in inorganic and hybrid lead halide perovskites.

Physical review materials·2020
Same journal

Structural pharmacology of TRPA1 channel.

Trends in pharmacological sciences·2026
Same journal

Recent advances in venom pharmacology reshaping venom-to-drug discovery.

Trends in pharmacological sciences·2026
Same journal

Engineering cells for solid tumor therapy.

Trends in pharmacological sciences·2026
Same journal

Targeting developmental reprogramming: hPSC insights for cancer interception.

Trends in pharmacological sciences·2026
Same journal

July 2026 issue first authors.

Trends in pharmacological sciences·2026
Same journal

Chronobiomaterials for circadian-aligned brain therapeutics.

Trends in pharmacological sciences·2026
See all related articles

The number of alpha 2-adrenoceptor subtypes is growing, but functional differences remain unclear. Further research is needed to confirm distinct pathways for targeted drug development.

Area of Science:

  • Pharmacology
  • Molecular Biology
  • Neuroscience

Background:

  • Receptor subtype classification is increasing based on molecular data.
  • Functional validation of these subtypes is lagging behind molecular identification.
  • Alpha 2-adrenoceptors are crucial in various physiological and pathological processes.

Purpose of the Study:

  • To review the pharmacology and function of putative alpha 2-adrenoceptor subtypes.
  • To discuss the discrepancies between molecular and functional classifications.
  • To explore the implications for selective drug development.

Main Methods:

  • Literature review of ligand-binding studies.
  • Analysis of molecular and functional data.
  • Discussion of species differences and receptor environment effects.

Related Experiment Videos

Main Results:

  • Molecular studies suggest an increasing number of alpha 2-adrenoceptor subtypes.
  • Functional evidence for distinct subtypes is less convincing.
  • Ligand selectivity and receptor state similarity may explain functional ambiguities.

Conclusions:

  • The functional significance of newly identified alpha 2-adrenoceptor subtypes requires further investigation.
  • Challenges in achieving ligand selectivity and understanding receptor environments impact pharmacological profiling.
  • Clarifying alpha 2-adrenoceptor subtypes is essential for developing targeted therapeutics.